436 related articles for article (PubMed ID: 20533028)
1. Prevalent vertebral fractures predict subsequent radiographic vertebral fractures in postmenopausal Korean women receiving antiresorptive agent.
Kim SH; Choi HS; Rhee Y; Kim KJ; Lim SK
Osteoporos Int; 2011 Mar; 22(3):781-7. PubMed ID: 20533028
[TBL] [Abstract][Full Text] [Related]
2. Prevalent vertebral fractures and minor vertebral deformities analyzed by vertebral fracture assessment (VFA) increases the risk of incident fractures in postmenopausal women: the FRODOS study.
Kanterewicz E; Puigoriol E; Rodríguez Cros JR; Peris P
Osteoporos Int; 2019 Oct; 30(10):2141-2149. PubMed ID: 31123788
[TBL] [Abstract][Full Text] [Related]
3. Vertebral fracture assessment by dual-energy X-ray absorptiometry along with bone mineral density in the evaluation of postmenopausal osteoporosis.
Shetty S; John B; Mohan S; Paul TV
Arch Osteoporos; 2020 Feb; 15(1):25. PubMed ID: 32095943
[TBL] [Abstract][Full Text] [Related]
4. Association of prevalent vertebral fractures, bone density, and alendronate treatment with incident vertebral fractures: effect of number and spinal location of fractures. The Fracture Intervention Trial Research Group.
Nevitt MC; Ross PD; Palermo L; Musliner T; Genant HK; Thompson DE
Bone; 1999 Nov; 25(5):613-9. PubMed ID: 10574584
[TBL] [Abstract][Full Text] [Related]
5. Association between prior non-spine non-hip fractures or prevalent radiographic vertebral deformities known to be at least 10 years old and incident hip fracture.
Schousboe JT; Fink HA; Lui LY; Taylor BC; Ensrud KE
J Bone Miner Res; 2006 Oct; 21(10):1557-64. PubMed ID: 16995810
[TBL] [Abstract][Full Text] [Related]
6. Thoracic kyphosis and rate of incident vertebral fractures: the Fracture Intervention Trial.
Katzman WB; Vittinghoff E; Kado DM; Lane NE; Ensrud KE; Shipp K
Osteoporos Int; 2016 Mar; 27(3):899-903. PubMed ID: 26782685
[TBL] [Abstract][Full Text] [Related]
7. Association between incident and baseline vertebral fractures in European women: vertebral fracture assessment in the Osteoporosis and Ultrasound Study (OPUS).
Ferrar L; Roux C; Felsenberg D; Glüer CC; Eastell R
Osteoporos Int; 2012 Jan; 23(1):59-65. PubMed ID: 21732219
[TBL] [Abstract][Full Text] [Related]
8. Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study.
Leslie WD; Martineau P; Bryanton M; Lix LM
Osteoporos Int; 2019 Jul; 30(7):1445-1453. PubMed ID: 31016351
[TBL] [Abstract][Full Text] [Related]
9. The importance of morphometric radiographic vertebral assessment for the detection of patients who need pharmacological treatment of osteoporosis among postmenopausal diabetic Korean women.
Choi YJ; Yang SO; Shin CS; Chung YS
Osteoporos Int; 2012 Aug; 23(8):2099-2105. PubMed ID: 21975560
[TBL] [Abstract][Full Text] [Related]
10. Vertebral fracture in postmenopausal Chinese women: a population-based study.
Cui L; Chen L; Xia W; Jiang Y; Cui L; Huang W; Wang W; Wang X; Pei Y; Zheng X; Wang Q; Ning Z; Li M; Wang O; Xing X; Lin Q; Yu W; Weng X; Xu L; Cummings SR
Osteoporos Int; 2017 Sep; 28(9):2583-2590. PubMed ID: 28560474
[TBL] [Abstract][Full Text] [Related]
11. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
Seibel MJ; Naganathan V; Barton I; Grauer A
J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403
[TBL] [Abstract][Full Text] [Related]
12. Quantitative computed tomography of the lumbar spine, not dual x-ray absorptiometry, is an independent predictor of prevalent vertebral fractures in postmenopausal women with osteopenia receiving long-term glucocorticoid and hormone-replacement therapy.
Rehman Q; Lang T; Modin G; Lane NE
Arthritis Rheum; 2002 May; 46(5):1292-7. PubMed ID: 12115236
[TBL] [Abstract][Full Text] [Related]
13. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
McClung MR; O'Donoghue ML; Papapoulos SE; Bone H; Langdahl B; Saag KG; Reid IR; Kiel DP; Cavallari I; Bonaca MP; Wiviott SD; de Villiers T; Ling X; Lippuner K; Nakamura T; Reginster JY; Rodriguez-Portales JA; Roux C; Zanchetta J; Zerbini CAF; Park JG; Im K; Cange A; Grip LT; Heyden N; DaSilva C; Cohn D; Massaad R; Scott BB; Verbruggen N; Gurner D; Miller DL; Blair ML; Polis AB; Stoch SA; Santora A; Lombardi A; Leung AT; Kaufman KD; Sabatine MS;
Lancet Diabetes Endocrinol; 2019 Dec; 7(12):899-911. PubMed ID: 31676222
[TBL] [Abstract][Full Text] [Related]
14. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.
Ettinger B; Black DM; Mitlak BH; Knickerbocker RK; Nickelsen T; Genant HK; Christiansen C; Delmas PD; Zanchetta JR; Stakkestad J; Glüer CC; Krueger K; Cohen FJ; Eckert S; Ensrud KE; Avioli LV; Lips P; Cummings SR
JAMA; 1999 Aug; 282(7):637-45. PubMed ID: 10517716
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for a first-incident radiographic vertebral fracture in women > or = 65 years of age: the study of osteoporotic fractures.
Nevitt MC; Cummings SR; Stone KL; Palermo L; Black DM; Bauer DC; Genant HK; Hochberg MC; Ensrud KE; Hillier TA; Cauley JA
J Bone Miner Res; 2005 Jan; 20(1):131-40. PubMed ID: 15619679
[TBL] [Abstract][Full Text] [Related]
16. Effects of 5-year treatment with elcatonin and alfacalcidol on lumbar bone mineral density and the incidence of vertebral fractures in postmenopausal women with osteoporosis: a retrospective study.
Iwamoto J; Takeda T; Ichimura S; Uzawa M
J Orthop Sci; 2002; 7(6):637-43. PubMed ID: 12486466
[TBL] [Abstract][Full Text] [Related]
17. Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy.
Sarkar S; Mitlak BH; Wong M; Stock JL; Black DM; Harper KD
J Bone Miner Res; 2002 Jan; 17(1):1-10. PubMed ID: 11771654
[TBL] [Abstract][Full Text] [Related]
18. Association between self-reported prior wrist fractures and risk of subsequent hip and radiographic vertebral fractures in older women: a prospective study.
Schousboe JT; Fink HA; Taylor BC; Stone KL; Hillier TA; Nevitt MC; Ensrud KE
J Bone Miner Res; 2005 Jan; 20(1):100-6. PubMed ID: 15619675
[TBL] [Abstract][Full Text] [Related]
19. The importance of absolute bone mineral density in the assessment of antiresorptive agents used for the prevention of osteoporotic fractures.
Kuroda T; Shiraki M; Shiraki Y; Tanaka S
J Clin Densitom; 2012; 15(4):392-398. PubMed ID: 22521539
[TBL] [Abstract][Full Text] [Related]
20. Biochemical markers for bone turnover predict risk of vertebral fractures in postmenopausal women over 10 years: the Japanese Population-based Osteoporosis (JPOS) Cohort Study.
Tamaki J; Iki M; Kadowaki E; Sato Y; Chiba Y; Akiba T; Matsumoto T; Nishino H; Kagamimori S; Kagawa Y; Yoneshima H;
Osteoporos Int; 2013 Mar; 24(3):887-97. PubMed ID: 22885773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
